Science and skin care merged at Induchem Companies’ 3rd Scientific Symposium: The Future Omics of the Skin.
The conference, held at the Apella Center, New York, featured presentations by panellists Dr Stuart Lindsey, Dr Patrick Robe, Dr Denis Wahler, and Sarah Jindal and covered single molecule technologies, metagenomics, enzynomics, the application of omics to understand molecular basis of disease, and where we stand with omics in skin care.
Sarah Jindal, senior beauty and personal care innovation and insights analyst at Mintel, closed the symposium with consumer data, product examples, and trend implications that bridged the gap and connected to links of omics and skin care. By taking advantage of the developments in the cost and efficiency of genomics (the study of genes and their function), lipidomics (largescale study of pathways and networks of cellular lipids in biological systems), and proteomics (large-scale study of proteins, particularly their structures and functions), scientists and brands are able to better predict skin care needs with more extensive gene maps. So what does that mean for the future of skin care? What does today’s skin care consumer want? From convenience to ultra-personalisation, customisation is the future and brands have begun to tailor skin care regimens using genetics in both the luxury and mass categories. With continued technological advances, the cost of testing will drop and greater competition and nuances to services and products will become available. As the industry progresses, brands will be able to focus on more niche concerns, such as protection from smog and urban dust.
These same procedures will also lead to a parallel path in dermacosmetics and create customised formulas for patients with issues such as eczema and rosacea in the future. As science progresses, ultimately, so will all of the skin care industry.
